Compare Revolution Medicines Inc. Common Stock (RVMD) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revolution Medicines Inc. Common Stock vs Consumer Staples Select Sector SPDR Fund — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B), while Consumer Staples Select Sector SPDR Fund trades at $83.37 (market cap $13.50B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 3× Consumer Staples Select Sector SPDR Fund's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and Consumer Staples Select Sector SPDR Fund for 72 Days on average.
| RVMD | XLP | |
|---|---|---|
Market Cap | $40.32B | $13.50B |
Volume | 4,855,734 | 14,599,953 |
Sector | Health | — |
52-Week High | $221.15 | $90.00 |
52-Week Low | $47.50 | $75.61 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $37.02B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLP trades at $83.43, up 2.12% with strong bullish technical signals from moving averages and oscillators. The ETF shows defensive sector strength, gaining 6.6% year-to-date while consumer discretionary lags. Analyst consensus is unanimously bullish with 100% buy ratings. Recent dividend declaration of $0.54 payable in September 2026 adds income appeal.
Outlook remains positive given consumer staples' defensive characteristics amid economic uncertainty. Key opportunities include sector outperformance and dividend yield, while risks center on interest rate sensitivity and potential consumer spending slowdown. The ETF's low 0.08% expense ratio provides cost advantage over peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
